Boehringer Ingleheim’s relatively new anticoagulant Pradaxa has hit blockbuster status, even amid hundreds of deaths and other serious injuries caused by bleeding problems experienced by users of the medication.
Lawyers representing individuals throughout the United States who are pursuing a Pradaxa lawsuit, after experiencing severe bleeding problems allegedly caused by the newer anticoagulant, will be meeting on Wednesday in…
The controversial blood thinner Pradaxa may have been responsible for another 117 deaths during the second quarter of 2011, according to a new report on problems submitted to the FDA.
Fears over bleeding problems with Pradaxa may have contributed to the FDA’s recent decision to delay their review of Eliquis, a proposed blood thinner that is part of the same…
The family of a Tennessee woman who died after experiencing a severe gastrointestinal bleed, has filed a wrongful death lawsuit over Pradaxa against Boehringer Ingelheim, alleging that the drug maker…
A group of New Zealand researchers indicate that the growing number of reports involving internal bleeding with Pradaxa, a new blood thinner, highlights the need for better prescriber education and…
A group of stroke experts has indicated that they are reviewing the safety of Pradaxa and other similar blood thinners, as they attempt to get a better idea of what…
A recent study involving the review of clinical data on the controversial new anticoagulent Pradaxa found an increased risk of heart attacks when compared to warfarin, but an overall decrease…
A non-profit watchdog group says consumers should be warned that side effects of St. John’s wort could interfere with other drugs, including antidepressants, birth control and blood thinners.
